Southern Methodist University
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Southern Methodist University sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).
Southern Methodist University: 17 sponsored US clinical trials, 1 recruiting.
Southern Methodist University sponsors 17 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 13 completed. 4 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Panic Disorder With Agoraphobia, with 1 trials.
Top-decile sponsor footprint
Southern Methodist University ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
13 of 15 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
17 total, page 1 of 1
Beetroot Juice NO Cold Study
NCT06416228
Positive Affect Treatment for Spanish-Speaking Individuals
NCT07493369
Daily Assessment of Mood and Social Media Behaviors Study
NCT04349423
ACT for High-risk Pregnancy
NCT04193514
Mindfulness-Based Physical Activity Intervention
NCT04086420
Cerebral Blood Flow Regulation and Concussions
NCT02754206
Nitrate Supplementation During Final Examination Stress
NCT03159273
Acceptance and Commitment Therapy for Nonsuicidal Self-injury
NCT03548402
Lifestyle Interventions for Generalized Anxiety Disorder
NCT01644812
Yoga for Stress and Mental Health
NCT01652807
Efficacy and Mechanisms of Psychosocial Treatments for Panic Disorder
NCT04366011
Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD)
NCT01199107
D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for Acrophobia
NCT01102803
Smoking Termination Enhancement Project (STEP)
NCT01065506
Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety
NCT00958880
Breathing Training for Asthma
NCT00975273
Mechanisms of Treatment Change in Panic Disorder and Agoraphobia
NCT03547180
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 4 |
Where Southern Methodist University enrollment is open (later-stage tilt)
1 recruiting of 17 indexed (6% open); 13 completed (76%).
Phase mix: 4 late (III/IV) vs 2 early (I/II) (later-stage heavy).
Top condition: Panic Disorder With Agoraphobia (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Southern Methodist University: open-pipeline peers nationwide
Peers matched on 17 registered trials and 6% open enrollment, not the therapeutic-area sidebar.
Southern Methodist University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 17 trials (± recruiting share)
- Achieve Life Sciences · 17 trials · 0% recruiting
- BioDelivery Sciences International · 17 trials · 6% recruiting
- Chugai Pharmaceutical · 17 trials · 24% recruiting
- ConvaTec · 17 trials · 18% recruiting
Sponsors near 6% open enrollment (± trial volume)
- Colgate Palmolive · 6% recruiting · 51 trials
- Durham VA Medical Center · 6% recruiting · 17 trials
- Essentia Health · 6% recruiting · 17 trials
- Madrigal Pharmaceuticals · 6% recruiting · 17 trials
Related
What to do with this Southern Methodist University page
17 registered trials is a research-attention snapshot, not an endorsement of Southern Methodist University or any single study.
- 1 of Southern Methodist University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Panic Disorder With Agoraphobia is the condition Southern Methodist University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Panic Disorder With Agoraphobia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Southern Methodist University pipeline card: 17 registered trials from official public datasets.Report a data error.